Healthtech Startups

Free to Feed provides consulting and advisory support to help parents meet their infant feeding goals. The company operates in the digital health and wellness space focused on feeding support.

2 investors

Freed builds an AI assistant for clinicians that generates clinical notes from patient encounters, offering customizable templates, visit prep summaries, patient-friendly instructions, referral and other letters, and suggested billable ICD-10, CPT, and E/M codes that can sync to an EHR. It serves healthcare providers looking to reduce documentation time.

2 investors

Freedom One Life designs and builds the Series 5 powered wheelchair, a powerchair developed and led by actual powerchair users for people with mobility and complex postural needs. The company builds each chair in-house and offers nationwide test drives across the UK.

2 investors

Frontera Health develops AI technology for Applied Behavior Analysis (ABA) that helps BCBAs and clinics work more efficiently and treat more children diagnosed with autism. The tools aim to increase patient access, improve clinic operations, and support more precise treatment plans for children and their families in the United States.

2 investors

Frontier provides employers with integrated healthcare solutions including primary care clinics, specialty care coordination with transparent pricing, and discounted medication management. The company serves corporate employers seeking to reduce healthcare costs and improve employee access to care.

2 investors

Fujifilm is a diversified manufacturer operating across healthcare (prevention, diagnosis, and treatment), electronics, business innovation, and imaging, producing products and services including film, photography, medical technology, and digital transformation solutions. It serves consumers and business customers globally across these fields.

2 investors

FUS Mobile develops the Neurolyser XR, a non-invasive medical device that uses high intensity focused ultrasound (HIFU) with fluoroscopic guidance to thermally ablate the lumbar medial branch nerve for treating chronic facet-mediated low back pain. It is intended for interventional pain management physicians and is approved in Europe and has US De Novo marketing authorization.

2 investors

Futura is a digital dental laboratory solution that provides dentists with an intraoral scanner, clinical management portal, and lab services with training and support. It serves dental practices seeking to digitize their operations and improve patient care efficiency.

2 investors

Future Cardia develops an implantable, under-the-skin cardiac monitor placed via a short office procedure for long-term monitoring of patients with arrhythmias and heart failure. The device is a Class II, 510(k) product aimed at chronic heart failure management and existing reimbursement structures.

2 investors

GLNK provides healthcare data intelligence for life sciences organizations, offering profiles of healthcare providers, institutional data, payments tracking, medical device utilization metrics, and prescribing patterns across the US healthcare ecosystem.

2 investors

Gale enables e-commerce businesses to accept HSA and FSA card payments and identify eligible products through an IRS-compliant inventory system. The platform targets online retailers selling health and wellness products, helping them reach approximately 80 million HSA/FSA shoppers.

2 investors

Galen AI develops a mobile health application that aggregates medical records from healthcare providers and wearable devices, then uses AI to provide personalized health insights and recommendations for patients managing multiple conditions.

2 investors

GalenusCare (ChorusRx) provides precision pharmacy services for PACE and hospice care programs, combining clinical pharmacists with AI-powered analytics to optimize medication regimens, reduce adverse drug events, and lower medical costs. Its services include medication regimen optimization, precision compliance packaging, symptom kits, and collaborative pharmacy management with value-based care agreements.

2 investors

GAMGEE develops personalised mRNA cancer vaccines for dogs, created from the animal's own tumour tissue to help its immune system fight the cancer. The company manages the full process end to end—from diagnosis and tissue sampling with the pet owner's vet, to genomic analysis and treatment delivery via veterinary oncologists—and is currently running clinical trials in Australia while accepting applications globally.

2 investors

Gardia offers a wearable emergency-call wristband with automatic fall detection, a built-in mobile connection, GPS, and speaker/microphone, plus a companion app for family members and an optional connection to a 24/7 professional emergency call center. It targets older and at-risk adults and their relatives in Germany, and helps customers claim reimbursement of service costs through nursing care insurance (Pflegekasse).

2 investors

Gateway Health recruits and helps international nurses immigrate to the United States, handling immigration and visa filings such as EB-3, TN, H-1B and related visas. It works with nurses from the Philippines, African countries, the Middle East, the Caribbean, the UK and Canada, and supports their cultural and clinical adjustment to life in the US.

2 investors

GattaCo develops a blood plasma separator device that enables point-of-care collection and transport of lab-quality plasma for remote blood testing and monitoring. The A-PON Plasma Separator uses passive elution technology to extract plasma from finger-stick blood samples for later laboratory analysis.

2 investors

GREEN VET provides diagnostic testing, health screening, and management services for companion animals, serving veterinarians and pet owners in South Korea. The company operates as a specialized animal healthcare provider offering laboratory diagnostics, digital pathology, and preventive care services.

2 investors

Gelesis develops an oral superabsorbent hydrogel platform (OHS) built from naturally derived materials that works locally in the GI tract to influence satiety signals and support metabolic health. Its product Plenity is a clinically studied aid for weight management in overweight or obese adults with a BMI of 25 to 40 when combined with diet and exercise.

2 investors

Gene S is an Australian biotechnology company providing Next Generation Sequencing solutions and gene testing software to laboratories and healthcare providers for delivering pharmacogenomic results.

2 investors

General Inception is an operational support and company building firm that handles day-to-day planning and execution for building companies, with a focus on life science tools and diagnostics.

2 investors

family.cards develops digital solutions to connect elderly Germans with their families and integrate them into digital channels. The company addresses the digital divide affecting 8 million seniors in Germany by creating intuitive, age-friendly technology platforms.

2 investors

Geneticure offers a patented genetic test that uses a cheek-swab DNA sample, analyzing 17 genotypes across 11 genes to recommend personalized hypertension (blood pressure) treatment plans. The test helps doctors prescribe effective treatments by assessing the responsiveness of the patient's cardiac, vascular, and renal systems, reducing trial-and-error prescribing.

2 investors

GenFleet is a biopharmaceutical company developing novel drug therapies focused on RAS targeting and antibody-drug conjugates (ADCs) to address unmet clinical needs in cancer and other serious diseases.

2 investors